Cargando…
Kynurenine metabolites predict survival in pulmonary arterial hypertension: A role for IL-6/IL-6Rα
Activation of the kynurenine pathway (KP) has been reported in patients with pulmonary arterial hypertension (PAH) undergoing PAH therapy. We aimed to determine KP-metabolism in treatment-naïve PAH patients, investigate its prognostic values, evaluate the effect of PAH therapy on KP-metabolites and...
Autores principales: | Cai, Zongye, Tian, Siyu, Klein, Theo, Tu, Ly, Geenen, Laurie W., Koudstaal, Thomas, van den Bosch, Annemien E., de Rijke, Yolanda B., Reiss, Irwin K. M., Boersma, Eric, van der Ley, Claude, Van Faassen, Martijn, Kema, Ido, Duncker, Dirk J., Boomars, Karin A., Tran-Lundmark, Karin, Guignabert, Christophe, Merkus, Daphne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9296482/ https://www.ncbi.nlm.nih.gov/pubmed/35853948 http://dx.doi.org/10.1038/s41598-022-15039-3 |
Ejemplares similares
-
Lower Plasma Melatonin Levels Predict Worse Long-Term Survival in Pulmonary Arterial Hypertension
por: Cai, Zongye, et al.
Publicado: (2020) -
Age‐ and disease‐specific changes of the kynurenine pathway in Parkinson’s and Alzheimer’s disease
por: Sorgdrager, Freek J. H., et al.
Publicado: (2019) -
Purinergic Dysfunction in Pulmonary Arterial Hypertension
por: Cai, Zongye, et al.
Publicado: (2020) -
Brain Kynurenine Pathway Metabolite Levels May Reflect Extent of Neuroinflammation in ALS, FTD and Early Onset AD
por: Heylen, Annelies, et al.
Publicado: (2023) -
The Prognostic Value of Soluble ST2 in Adults with Pulmonary Hypertension
por: Geenen, Laurie W., et al.
Publicado: (2019)